In humans, ATP9A homozygous recessive mutations cause neurodevelopmental defects leading to postnatal microcephaly, intellectual disability, attention deficit hyperactivity disorder, and hypotonia71–73. This evidence concerns the gene ATP9A and attention deficit-hyperactivity disorder.